Robust data on patient-reported outcome measures comparing treatments for clinically localized prostate cancer are lacking. We investigated the effects of active monitoring, radical prostatectomy, and ...

After surgical removal of the prostate to treat prostate cancer, clinicians monitor Prostate Specific Antigen (PSA) levels. Persistently elevated PSA levels indicate residual cancer and are linked to ...

Editor's note: second of two parts; read part one here. In the first part of our series, we described how PSA is used as a screening tool to help detect prostate cancer in men who don't have symptoms.

A new blood test could help doctors identify whether a treatment for advanced prostate cancer is failing weeks earlier than ...

Researchers from Korea say that inpatient prostate-specific antigen (PSA) levels should be ignored for the purposes of serial monitoring, after finding that they are significantly reduced compared ...

Prostate cancer is a complex disease. Doctors cannot always predict how fast or slow it will grow. Nor do they agree on when to treat it, or which treatments to use. Predicting and monitoring the ...

A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...

Prostate-specific antigen (PSA) is one of the few molecular markers routinely used for detection, risk stratification and monitoring of a common cancer. PSA is specific to the prostate but not to ...